COHANCE LIFESCIENCES [COHANCE] vs Mankind Pharma [MANKIND] Detailed Stock Comparison

COHANCE LIFESCIENCES

NSE

Mankind Pharma

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: COHANCE LIFESCIENCES wins in 3 metrics, Mankind Pharma wins in 16 metrics, with 0 ties. Mankind Pharma appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	COHANCE LIFESCIENCES	Mankind Pharma	Better
P/E Ratio (TTM)	89.01	54.55	Mankind Pharma
Price-to-Book Ratio	14.00	7.31	Mankind Pharma
Debt-to-Equity Ratio	15.16	58.43	COHANCE LIFESCIENCES
PEG Ratio	-8.21	41.13	COHANCE LIFESCIENCES
EV/EBITDA	63.68	35.74	Mankind Pharma
Profit Margin (TTM)	22.37%	14.66%	COHANCE LIFESCIENCES
Operating Margin (TTM)	11.64%	17.59%	Mankind Pharma
EBITDA Margin (TTM)	11.64%	17.59%	Mankind Pharma
Return on Equity	13.61%	13.67%	Mankind Pharma
Return on Assets (TTM)	7.04%	7.17%	Mankind Pharma
Free Cash Flow (TTM)	$1.32B	$18.83B	Mankind Pharma
Dividend Yield	N/A	0.04%	N/A
1-Year Return	-13.43%	15.49%	Mankind Pharma
Price-to-Sales Ratio (TTM)	29.80	8.11	Mankind Pharma
Enterprise Value	$238.94B	$1,109.27B	Mankind Pharma
EV/Revenue Ratio	19.95	8.59	Mankind Pharma
Gross Profit Margin (TTM)	66.67%	70.49%	Mankind Pharma
Revenue per Share (TTM)	$47	$317	Mankind Pharma
Earnings per Share (Diluted)	$10.48	$46.52	Mankind Pharma
Beta (Stock Volatility)	0.64	0.35	Mankind Pharma

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

COHANCE LIFESCIENCES vs Mankind Pharma Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
COHANCE LIFESCIENCES	0.03%	-4.72%	-6.52%	-11.99%	-11.99%	-11.99%
Mankind Pharma	-2.79%	-3.87%	1.46%	1.13%	-1.40%	-14.37%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
COHANCE LIFESCIENCES	-13.43%	-13.43%	-13.43%	-13.43%	-13.43%	-13.43%
Mankind Pharma	15.49%	76.92%	76.92%	76.92%	76.92%	76.92%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

COHANCE LIFESCIENCES (COHANCE): View Full Stock Overview

Mankind Pharma (MANKIND): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: COHANCE LIFESCIENCES vs Mankind Pharma

Metric	COHANCE	MANKIND
Market Information
Market Cap i	₹356.88B	₹1.05T
Market Cap Category	Large cap	Large cap
10 Day Avg. Volume i	148,128	516,419
90 Day Avg. Volume i	245,972	789,842
Last Close	₹933.10	₹2,467.10
52 Week Range	₹919.00 - ₹1,123.40	₹2,028.05 - ₹3,054.80
% from 52W High	-16.94%	-19.24%
All-Time High	₹1,123.40 (May 05, 2025)	₹3,054.80 (Dec 23, 2024)
% from All-Time High	-16.94%	-19.24%
Growth Metrics
Quarterly Revenue Growth	0.59%	0.23%
Quarterly Earnings Growth	-0.21%	-0.18%
Financial Health
Profit Margin (TTM) i	0.22%	0.15%
Operating Margin (TTM) i	0.12%	0.18%
Return on Equity (TTM) i	0.14%	0.14%
Debt to Equity (MRQ) i	15.16	58.43
Cash & Liquidity
Book Value per Share (MRQ)	₹66.64	₹347.39
Cash per Share (MRQ)	₹11.01	₹61.20
Operating Cash Flow (TTM) i	₹2.88B	₹26.50B
Levered Free Cash Flow (TTM) i	₹1.48B	₹19.91B
Dividends
Last 12-Month Dividend Yield i	N/A	0.04%
Last 12-Month Dividend i	N/A	₹1.00

Valuation & Enterprise Metrics Analysis: COHANCE LIFESCIENCES vs Mankind Pharma

Metric	COHANCE	MANKIND
Price Ratios
P/E Ratio (TTM) i	89.01	54.55
Forward P/E i	39.72	41.13
PEG Ratio i	-8.21	41.13
Price to Sales (TTM) i	29.80	8.11
Price to Book (MRQ) i	14.00	7.31
Market Capitalization
Market Capitalization i	₹356.88B	₹1.05T
Enterprise Value i	₹238.94B	₹1.11T
Enterprise Value Metrics
Enterprise to Revenue i	19.95	8.59
Enterprise to EBITDA i	63.68	35.74
Risk & Other Metrics
Beta i	0.64	0.35
Book Value per Share (MRQ) i	₹66.64	₹347.39

Financial Statements Comparison: COHANCE LIFESCIENCES vs Mankind Pharma

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	COHANCE	MANKIND
Revenue/Sales i	₹4.02B	₹35.70B
Cost of Goods Sold i	₹1.34B	₹10.54B
Gross Profit i	₹2.68B	₹25.17B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹467.80M	₹6.28B
EBITDA i	₹841.30M	₹9.30B
Pre-Tax Income i	₹516.00M	₹5.40B
Income Tax i	₹128.70M	₹958.70M
Net Income (Profit) i	₹387.30M	₹4.45B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	COHANCE	MANKIND
Cash & Equivalents i	₹854.00M	₹4.07B
Total Current Assets i	₹8.89B	₹69.88B
Total Current Liabilities i	₹3.65B	₹56.64B
Long-Term Debt i	₹1.76B	₹55.40B
Total Shareholders Equity i	₹18.41B	₹145.68B
Retained Earnings i	N/A	₹119.07B
Property, Plant & Equipment i	₹9.95B	₹29.08B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	COHANCE	MANKIND
Operating Cash Flow i	N/A	₹3.41B
Capital Expenditures i	N/A	₹-1.30B
Free Cash Flow i	N/A	₹3.51B
Debt Repayment i	N/A	₹-191.39M
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	COHANCE	MANKIND
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	148,128	516,419
Average Daily Volume (90 Day) i	245,972	789,842
Shares Outstanding i	254.56M	412.58M
Float Shares i	152.71M	105.99M
% Held by Insiders i	0.73%	0.74%
% Held by Institutions i	0.15%	0.18%

Dividend Analysis & Yield Comparison: COHANCE LIFESCIENCES vs Mankind Pharma

Metric	COHANCE	MANKIND
Last 12-Month Dividend i	N/A	₹1.00
Last 12-Month Dividend Yield i	N/A	0.04%
3-Year Avg Annual Dividend i	N/A	₹0.33
3-Year Avg Dividend Yield i	N/A	0.04%
3-Year Total Dividends i	N/A	₹1.00
Ex-Dividend Date	N/A	Aug 08, 2025

COHANCE LIFESCIENCES [COHANCE] vs Mankind Pharma [MANKIND] Detailed Stock Comparison